Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.16 per share which met the analyst consensus estimate. This is a 4.5 percent increase over earnings of $1.11 per share from the same period last year.
Why Enanta Shares Are Plunging Today
Enanta Pharmaceuticals Inc's (NASDAQ: ENTA) investigational COVID-19 pill, EDP-235, met its primary endpoints of safety and tolerability in its Phase 2 SPRINT trial but yielded
